Drugs / ADV6209
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03931057 | Nov 2020 → Sep 2021 | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADV6209 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03931057 ↗ |
| Route | Oral | “ADV6209 (= gamma-cyclodextrin-Midazolam) 0.25 mg/kg p.o. once 30 min. before anesthesia” NCT03931057 ↗ |